Publication | Open Access
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis
290
Citations
11
References
2018
Year
Combination therapy with TOF might have the potential to control refractory anti-MDA5 Ab+ DM-ILD.
| Year | Citations | |
|---|---|---|
Page 1
Page 1